Genethon Signs Licensing Agreement With AskBio for the Development of an Investigational Gene Therapy for Pompe Disease

# Genethon Signs Licensing Agreement With AskBio for the Development of an Investigational Gene Therapy for Pompe Disease

**Published:** 1/14/2026

**Category:** science

---

PARIS--(BUSINESS WIRE)--Genethon's agreement with AskBio, enables the development of a gene therapy for patients suffering from this particularly severe condition

---

*This article was automatically generated and curated by our AI news platform.*